InvestorsHub Logo
Followers 5
Posts 224
Boards Moderated 0
Alias Born 03/19/2015

Re: jessellivermore post# 262858

Monday, 04/06/2020 7:57:00 AM

Monday, April 06, 2020 7:57:00 AM

Post# of 425795
I am with pharmadude and Cardiologymd on this one.
The difference now is that EPA (thanks to Amarin) has demonstrated benefit in cardiovascular disease. So regardless of the label, pharmacists could as far as I understand substitute for the generic regardless of the official label.

Look they are still substituting Vascepa for omega-3 which is even a more puzzling situation even today.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News